# Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-squamous-cell-non-small-cell-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Julie R. Brahmer,Karen L. Reckamp,Paul Baas,Lucio Crinò,Wilfried Eberhardt,Elena Poddubskaya,Scott Antonia,Adam Płużański,Everett E. Vokes,Esther Holgado,David Waterhouse,Neal Ready,Justin F. Gainor,Osvaldo Arén Frontera,Libor Havel,Martin Steins,Marina Chiara Garassino,Joachim G.J.V. Aerts,Manuel Dómine,Luis Paz‐Ares,Martin Reck,Christine Baudelet,Christopher Harbison,Brian Lestini,David R. Spigel |
| Citations | 8,599 |
| DOI | 10.1056/nejmoa1504627 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1504627?articleTools=true |
| OpenAlex ID | https://openalex.org/W2156353875 |
| PMID | 26028407 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Julie R. Brahmer](https://scholariq.org/researchers/julie-r-brahmer/)
- [Justin F. Gainor](https://scholariq.org/researchers/justin-f-gainor/)
- [Marina Chiara Garassino](https://scholariq.org/researchers/marina-chiara-garassino/)
- [David R. Spigel](https://scholariq.org/researchers/david-r-spigel/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.